Proxy Votes Now

Home › Funds › Capital Group › Global Growth Fund

Global Growth Fund proxy voting record 2025-2026

Fund family: Capital Group · Filed by AMERICAN FUNDS INSURANCE SERIES (CIK 729528) · SEC series S000008786

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,443 with, 101 against, 6 abstentions (not counted as with management); 27 items carried no recommendation. Shareholder proposals: 39 FOR, 77 AGAINST, 1 abstained, by the filing’s own vote-source field.

Compared with Capital Group as a whole

The same two figures as Capital Group’s manager page (120,065 ballot items across 80 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsCapital GroupItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)96.5%2,07196.6%98,284
Backed environmental and social shareholder proposals at US companies0.0%511.3%2,130

Where this fund voted differently from most Capital Group funds

Each ballot item this fund voted is set against the votes of the other Capital Group funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Capital Group funds on 14 items (0.6% of the 2,219 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Capital Group fundsMgmtResult
Novo Nordisk A/S2026-03-26Reelect Cees de Jong (Vice Chair) as DirectorForABSTAIN — 11 of 12 Capital Group fundsFor—
BeOne Medicines Ltd.2026-06-11THAT Dr. Felix J. Baker be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.ForAGAINST — 6 of 6 Capital Group fundsForElected, 83.3% support
BeOne Medicines Ltd.2026-06-11THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the CompAgainstFOR — 6 of 6 Capital Group fundsAgainstApproved, 70.0% support
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Approve Compensation of Bernard Arnault, Chairman and CEOForAGAINST — 15 of 18 Capital Group fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Renew Appointment of Diego Della Valle as CensorForAGAINST — 15 of 18 Capital Group fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Renew Appointment of Lord Powell of Bayswater as CensorForAGAINST — 15 of 18 Capital Group fundsFor—
Amazon.com, Inc.2026-05-20ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATIONAgainstFOR — 17 of 24 Capital Group fundsAgainstApproved, 94.0% support
Shopify Inc.2026-06-16Shareholder Adopt a Policy on Responsible Use of Artificial Intelligence ("AI") in the Company's Business and OperationsForAGAINST — 9 of 12 Capital Group fundsAgainst—
UnitedHealth Group Incorporated2026-06-01Election of Directors: Scott Gottlieb, M.D.AgainstFOR — 13 of 19 Capital Group fundsAgainstElected, 93.0% support
The Sherwin-Williams Company2026-04-22Election of 9 Directors: Jeff M. FettigAgainstFOR — 3 of 3 Capital Group fundsAgainstElected, 96.9% support
Oracle Corporation2025-11-18Advisory Vote to Approve the Compensation of our Named Executive OfficersAgainstFOR — 15 of 25 Capital Group fundsAgainstPassed (calculated), 81.9% support
Novo Nordisk A/S2026-03-26Elect Helena Saxon as New DirectorForABSTAIN — 8 of 12 Capital Group fundsFor—
Carvana Co.2026-05-05To ratify the appointment of Grant Thornton LLP as Carvana's independent registered public accounting firm for the year ending December 31, 2026.ForAGAINST — 5 of 9 Capital Group fundsForApproved, 98.6% support
Dollar General Corporation2026-05-28Shareholder To vote on a shareholder proposal asking the Board to amend the director resignation policy to require directors who do not receive a majority vote in uncontested elections to leave the Board within nine months.AgainstFOR — 2 of 3 Capital Group fundsForNot approved, 15.5% support

Download all 14 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,2510
Corporate Governance40636
Compensation3024
Capital Structure2670
Audit-related1720
Say-on-Pay800
Other Social Issues3124
Environment or Climate2221
Extraordinary Transactions200
Human Rights or Human Capital/workforce1111

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Microsoft CorporationDecember 5, 2025$399M216
Broadcom Inc.April 20, 2026$323M100
Micron Technology, Inc.January 15, 2026$312M121
Meta Platforms, Inc.May 27, 2026$260M229
Alphabet Inc.June 5, 2026$161M2310
Starbucks CorporationMarch 25, 2026$137M195
Citigroup Inc.May 20, 2026$131M160
NVIDIA CorporationJune 24, 2026$124M164

Notable votes against management

MeetingCompanyProposalFundMgmt
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
January 15, 2026Micron Technology, Inc.SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
March 25, 2026Starbucks CorporationShareholder proposal requesting adoption of an independent board chair policy Shareholder proposalAgainstFor
March 25, 2026Starbucks CorporationShareholder proposal requesting a report on the Company's apparent exclusion of detransitioning in its healthcare coverage Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst

Search this fund’s votes by company

2,581 ballot items at 186 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Global Growth Fund voted at 186 shareholder meetings of 168 companies, on 2,581 ballot items in all. Where management made a recommendation, the fund followed it on 95.8% of the items and voted against it 101 times. Its most frequent area of disagreement was corporate governance (36 of its votes against management). It voted FOR 33.6% of the 116 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals about as often as Capital Group's funds as a whole (96.5% against 96.6%). It voted differently from most Capital Group funds on 14 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Capital Group’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.